evidence table
L-Carnitine Exercise Recovery Randomized Trial Evidence Table
Structured evidence table for L-Carnitine Exercise Recovery Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| L-Carnitine Exercise Recovery Randomized Trial | The results of a prior study confirmed the protective benefits of L-carnitine due to suppression of inflammation, oxidative stress, and increased autophagy (Khedr and Werida). | 1 | Werida Rehab H. (2026) | Therapeutic potential of L-carnitine in coronary artery disease: a systematic review |
| L-Carnitine Exercise Recovery Randomized Trial | Several experimental and clinical studies have suggested that L-carnitine supplementation may confer cardiovascular benefits in CAD patients, including improved cardiac metabolism, reduced oxidative stress, attenuation of inflammatory responses, and enhanced functional outcomes (Da Silva Guimarães et al.; Dastan et al.; Lee et al.; Lee et al.; Pastoris et al.; Singhai et al.; Tarantini et al.; Xue et al.). | 1 | Werida Rehab H. (2026) | Therapeutic potential of L-carnitine in coronary artery disease: a systematic review |
| L-Carnitine Exercise Recovery Randomized Trial | To our best knowledge, this is the first systematic review to address these gaps by synthesizing evidence in CAD patients across mechanistic markers such as oxidative stress, inflammatory mediators, autophagy-related markers and post-PCI myocardial-injury biomarkers together with clinical endpoints such as ventricular arrythmia, mortality and angina. | 1 | Werida Rehab H. (2026) | Therapeutic potential of L-carnitine in coronary artery disease: a systematic review |
| L-Carnitine Exercise Recovery Randomized Trial | 2019 2019 2015 Cardiovascular disease (CVD) is the predominant cause of death worldwide, with a substantial proportion attributable to ischemic heart disease, caused by atherosclerotic coronary artery disease (CAD) (Glovaci et al.; Sarrafzadegan and Mohammadifard). | 1 | Werida Rehab H. (2026) | Therapeutic potential of L-carnitine in coronary artery disease: a systematic review |
| L-Carnitine Exercise Recovery Randomized Trial | Aging is closely associated with oxidative stress, mitochondrial dysfunction, chronic inflammation, and progressive declines in muscle and cognitive function. | 4 | Wang X (2026) | Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. |
| L-Carnitine Exercise Recovery Randomized Trial | Evidence on NAC suggests context-dependent effects, with supplementation improving glutathione availability, fatigue resistance, and exercise performance in individuals with low baseline glutathione, while results remain inconsistent in healthy populations. | 4 | Wang X (2026) | Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. |
| L-Carnitine Exercise Recovery Randomized Trial | Exercise is widely recognized as the most effective non-pharmacological strategy to counteract these processes; however, its benefits may be potentiated by targeted nutritional interventions. | 4 | Wang X (2026) | Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. |
Source documents